{"id":3503,"date":"2017-12-01T10:25:33","date_gmt":"2017-12-01T15:25:33","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3503"},"modified":"2017-12-03T07:19:25","modified_gmt":"2017-12-03T12:19:25","slug":"ipo-pipeline-new-filings-updated-terms-week-ending-12-1-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-new-filings-updated-terms-week-ending-12-1-17\/","title":{"rendered":"IPO Pipeline: New Filings &#038; Updated Terms (Week ending 12.1.17)"},"content":{"rendered":"<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/09\/Screen-Shot-2017-09-22-at-9.34.24-AM.png\"><br \/>\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 59 active IPOs in the pipeline as of December 1, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-01-at-10.10.08-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-3504\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-01-at-10.10.08-AM.png\" alt=\"Screen Shot 2017-12-01 at 10.10.08 AM\" width=\"648\" height=\"395\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-01-at-10.10.08-AM.png 648w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-01-at-10.10.08-AM-600x366.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/12\/Screen-Shot-2017-12-01-at-10.10.08-AM-300x183.png 300w\" sizes=\"(max-width: 648px) 100vw, 648px\" \/><\/a><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>None to Report<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>UPDATED TERMS<\/strong><\/span><\/p>\n<p>Company: Denali Therapeutics Inc<br \/>\nSymbol: DNLI<br \/>\nDescription: Their goal is to discover and develop therapeutics to defeat degeneration.<br \/>\nShares: 8.33 million<br \/>\nPrice Range: $17.00-$19.00<br \/>\nTrade Date: 12\/8<br \/>\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley<br \/>\nCo-Manager(s): Evercore ISI<br \/>\nFiled: 11-27-17<\/p>\n<p>Company: Odonate Therapeutics, LLC<br \/>\nSymbol: ODT<br \/>\nDescription: They are a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer.<br \/>\nShares: 5.88 million<br \/>\nPrice Range: $24.00-$27.00<br \/>\nTrade Date: 12\/7<br \/>\nUnderwriter(s): Goldman Sachs, Jefferies<br \/>\nCo-Manager: Cowen<br \/>\nTerms Added: 11-27-17<\/p>\n<p>Company: Quanterix Corporation<br \/>\nSymbol: QTRX<br \/>\nDescription: They are a life sciences company that has developed a next generation, ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics.<br \/>\nShares: 3.34 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nTrade Date: 12\/7<br \/>\nUnderwriter(s): J.P. Morgan, Leerink<br \/>\nCo-Manager(s): BTIG, Evercore ISI<br \/>\nTerms Added: 11-27-17<\/p>\n<p>Company: Luther Burbank Corporation<br \/>\nSymbol: LBC<br \/>\nDescription: They are Luther Burbank Corporation, a bank holding company headquartered in Santa Rosa, Sonoma County, California.<br \/>\nShares: 11.35 million<br \/>\nPrice Range: $10.50-$12.50<br \/>\nTrade Date: 12\/8<br \/>\nUnderwriter(s): Keefe Bruyette &amp; Woods, Sandler O&#8217; Neill<br \/>\nCo-Manager(s): Piper Jaffray, D.A. Davidson<br \/>\nFiled: 11-27-17<\/p>\n<p>Company: CURO Group Holdings Corp.<br \/>\nSymbol: CURO<br \/>\nDescription: They are a growth-oriented, technology-enabled, highly-diversified consumer finance company serving a wide range of underbanked consumers in the United States, Canada and the United Kingdom and are a market leader in our industry based on revenues.<br \/>\nShares: 6.67 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nTrade Date: 12\/7<br \/>\nUnderwriter(s): Credit Suisse, Jefferies, Stephens Inc.<br \/>\nCo-Manager(s): William Blair, Janney Montgomery Scott<br \/>\nTerms Added: 11-28-17<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 59 active IPOs in the pipeline as of December 1, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS &nbsp; None[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3503","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3503"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3503\/revisions"}],"predecessor-version":[{"id":3526,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3503\/revisions\/3526"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}